F C BAILEY
Overview
Explore the profile of F C BAILEY including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maier K, NELSON C, BAILEY F, Klaine S, Knight A
Bull Environ Contam Toxicol
. 1998 Apr;
60(3):409-16.
PMID: 9528700
No abstract available.
2.
Houghton P, BAILEY F, Germain G, GRINDEY G, Howbert J, HOUGHTON J
Biochem Pharmacol
. 1990 Apr;
39(7):1187-92.
PMID: 2322303
The cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-urea (MPCU) has been examined in a cloned line of GC3 human colon adenocarcinoma cells. There was a rapid concentrative accumulation of drug, which could be...
3.
Houghton P, BAILEY F, HOUGHTON J, Murti K, Howbert J, GRINDEY G
Cancer Res
. 1990 Feb;
50(3):664-8.
PMID: 2297707
N-(4-Methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (MPCU) is a new agent that exhibits high therapeutic activity against human and rodent tumor models. Initial studies indicated that in vitro [3H]MPCU was concentrated 4- to 6-fold in...
4.
Houghton P, BAILEY F, Germain G, GRINDEY G, Witt B, HOUGHTON J
Cancer Res
. 1990 Jan;
50(2):318-22.
PMID: 2295071
Diarylsulfonylureas have been shown to have therapeutic activity against rodent and human tumor models, notably causing regressions in some lines of human colon adenocarcinomas in mice. At present the mechanism...
5.